Out of the 11 protein coding genes encompassing the deletion intervals of our patients, DLGAP2 and ARHGEF10 appear to be, according to their expression profile and the assessed role in neural morphogenesis, differentiation and function [13,14,15,16], bona fide candidates for neurodevelopmental disorders. The gene discussed is DLGAP2; the disease is neurodevelopmental disorder.